anti-CLL1 CAR T-cell therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for anti-CLL1 CAR T-cell therapy, covering 2021-05-13 to 2021-05-13. Get the full timeline:
Most recent: Clinical Trial Update: Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]